Last reviewed 2026-04-19 · How we verify

Metformin and melatonin gel

Amira ragab · Phase 2 active Small molecule

Metformin and melatonin gel is a Small molecule drug developed by Amira ragab. It is currently in Phase 2 development.

At a glance

Generic name	Metformin and melatonin gel
Sponsor	Amira ragab
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluation of Melatonin and Metformin Loaded Nanoparticles in the Treatment of Periodontal Intra-bony Defects (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Metformin and melatonin gel CI brief — competitive landscape report
Metformin and melatonin gel updates RSS · CI watch RSS
Amira ragab portfolio CI

Frequently asked questions about Metformin and melatonin gel

What is Metformin and melatonin gel?

Metformin and melatonin gel is a Small molecule drug developed by Amira ragab.

Who makes Metformin and melatonin gel?

Metformin and melatonin gel is developed by Amira ragab (see full Amira ragab pipeline at /company/amira-ragab).

What development phase is Metformin and melatonin gel in?

Metformin and melatonin gel is in Phase 2.

Manufacturer: Amira ragab — full pipeline
Compare: Metformin and melatonin gel vs similar drugs
Pricing: Metformin and melatonin gel cost, discount & access